Literature DB >> 20102409

Hepcidin messenger RNA expression in human lymphocytes.

Jorge P Pinto1, Vera Dias, Heinz Zoller, Graça Porto, Helena Carmo, Félix Carvalho, Maria de Sousa.   

Abstract

Hepcidin regulates intracellular iron levels by interacting with and promoting the degradation of ferroportin, a membrane protein and the only known cellular iron exporter. Studies of hepcidin expression and regulation have focused on its effects in innate immunity and as a regulator of systemic iron metabolism. In the present study we characterized the expression of hepcidin messenger RNA (mRNA) in human peripheral blood mononuclear cells (PBMCs) with a focus on peripheral blood lymphocytes (PBLs). We found that (1) all human PBMCs analyzed express basal hepcidin mRNA levels; (2) hepcidin mRNA expression increases after T-lymphocyte activation; (3) expression by PBLs increases in response to challenge by holotransferrin (Fe-TF) and by ferric citrate in vitro; (4) the Fe-TF-mediated up-regulation of hepcidin decreases ferroportin expression at the cytoplasmic membrane of PBLs; and (5) silencing of tumour necrosis factor-alpha (TNF-alpha) abrogates the effect of Fe-TF. In summary, we show that hepcidin expression determines intracellular iron levels by regulating the expression of ferroportin, as described in other cells, and that inappropriately low expression of hepcidin impairs normal lymphocyte proliferation. The results establish hepcidin as a new player in lymphocyte biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102409      PMCID: PMC2878466          DOI: 10.1111/j.1365-2567.2009.03226.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Non-transferrin-bound iron and cellular toxicity.

Authors:  G J Anderson
Journal:  J Gastroenterol Hepatol       Date:  1999-02       Impact factor: 4.029

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens.

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Vivekanand Datta; Xavier Lauth; Randall S Johnson; Victor Nizet
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

4.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.

Authors:  Jaroslav Truksa; Hongfan Peng; Pauline Lee; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity.

Authors:  L I Gordon; S G Brown; M S Tallman; A W Rademaker; S A Weitzman; H M Lazarus; C H Kelley; C Mangan; H Rubin; R M Fox
Journal:  Free Radic Biol Med       Date:  1995-03       Impact factor: 7.376

6.  Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.

Authors:  Marco Constante; Wenlei Jiang; Dongmei Wang; Valérie-Ann Raymond; Marc Bilodeau; Manuela M Santos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-03-24       Impact factor: 4.052

7.  The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.

Authors:  Eugénia Cruz; Graça Melo; Rosa Lacerda; Susana Almeida; Graça Porto
Journal:  Blood Cells Mol Dis       Date:  2006-06-09       Impact factor: 3.039

8.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

Review 9.  Regulation of iron metabolism by hepcidin.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Annu Rev Nutr       Date:  2006       Impact factor: 11.848

10.  Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man.

Authors:  M Santos; M W Schilham; L H Rademakers; J J Marx; M de Sousa; H Clevers
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  14 in total

1.  Source of iron overload in multiple sclerosis.

Authors:  Diego Di Lorenzo; Giorgio Biasiotto; Isabella Zanella
Journal:  Cell Mol Life Sci       Date:  2014-05-16       Impact factor: 9.261

2.  [Anemia in patients with rheumatoid arthritis].

Authors:  M Wahle
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

Review 3.  Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin.

Authors:  Maria Carlota Dao; Simin Nikbin Meydani
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

4.  Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent.

Authors:  Xinggang Wu; Lai-Ming Yung; Wai-Hang Cheng; Paul B Yu; Jodie L Babitt; Herbert Y Lin; Yin Xia
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Physiological implications of NTBI uptake by T lymphocytes.

Authors:  Jorge P Pinto; João Arezes; Vera Dias; Susana Oliveira; Inês Vieira; Mónica Costa; Matthijn Vos; Anna Carlsson; Yuri Rikers; Maria Rangel; Graça Porto
Journal:  Front Pharmacol       Date:  2014-02-26       Impact factor: 5.810

Review 6.  Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis.

Authors:  Javier Arranz-Trullén; Lu Lu; David Pulido; Sanjib Bhakta; Ester Boix
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

7.  Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.

Authors:  Andrew E Armitage; Andrea R Stacey; Eleni Giannoulatou; Elizabeth Marshall; Pamela Sturges; Kamaljit Chatha; Nicola M G Smith; XiaoJie Huang; XiaoNing Xu; Sant-Rayn Pasricha; Ning Li; Hao Wu; Craig Webster; Andrew M Prentice; Pierre Pellegrino; Ian Williams; Phillip J Norris; Hal Drakesmith; Persephone Borrow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

8.  Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species.

Authors:  Joao Arezes; Monica Costa; Ines Vieira; Vera Dias; Xiao L Kong; Rui Fernandes; Matthijn Vos; Anna Carlsson; Yuri Rikers; Graça Porto; Maria Rangel; Robert C Hider; Jorge P Pinto
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  Hepcidin expression in psoriasis patients.

Authors:  Nursel Dilek; Aziz Ramazan Dilek; Kazim Sahin; Neşe Kaklıkkaya; Yunus Saral
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

10.  Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.

Authors:  Ying-Hsien Huang; Ho-Chang Kuo; Fu-Chen Huang; Hong-Ren Yu; Kai-Sheng Hsieh; Ya-Ling Yang; Jiunn-Ming Sheen; Sung-Chou Li; Hsing-Chun Kuo
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.